Nemaura Medical Inc
F:N18A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nemaura Medical Inc
F:N18A
|
US |
|
Salim Ivomas Pratama Tbk PT
IDX:SIMP
|
ID |
|
Investigator Resources Ltd
ASX:IVR
|
AU |
|
Qrf Comm Va
F:2QR
|
BE |
|
N
|
Nemetschek SE
DUS:NEM
|
DE |
|
P
|
Phoenix Asia Holdings Ltd
NASDAQ:PHOE
|
HK |
|
Dropsuite Ltd
ASX:DSE
|
AU |
|
John Wood Group PLC
LSE:WG
|
UK |
|
X
|
Xencor Inc
F:XE9
|
US |
|
C
|
Cooper Metals Ltd
ASX:CPM
|
AU |
|
Foghorn Therapeutics Inc.
NASDAQ:FHTX
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is N18A's stock price target?
Not Available
N18A doesn't have any price targets made by Wall Street professionals.
What is Nemaura Medical Inc's Revenue forecast?
Projected CAGR
322%
The
compound annual growth rate
of
Nemaura Medical Inc's revenue for the next 2 years is
322%.